Evidence map›Paper›PMID 33301468›Full record

ArticlePloS one2020

Association between sinusitis and relapse and changes in the myeloperoxidase-antineutrophil cytoplasmic antibody in microscopic polyangiitis.

Hiroya Tanaka, Makoto Yamaguchi, Takayuki Katsuno, Hirokazu Sugiyama, Shiho Iwagaitsu, Hironobu Nobata, Hiroshi Kinashi, Shogo Banno, Takuji Ishimoto, Yasuhiko Ito

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hiroya TanakaDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Makoto YamaguchiDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Takayuki KatsunoDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Hirokazu SugiyamaDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Shiho IwagaitsuDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Hironobu NobataDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Hiroshi KinashiDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Shogo BannoDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Takuji IshimotoDepartment of Nephrology and Renal Replacement Therapy, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yasuhiko ItoDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.ORCID 0000-0002-9676-6961
Aichi Medical University · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have evaluated the risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and the biomarkers of AAV for predicting relapse. However, little is known about the association between the presence of sinusitis and relapse and changes in the ANCA levels in AAV. This single-center, retrospective cohort study included 104 consecutive patients who were newly diagnosed with myeloperoxidase (MPO)-ANCA-positive microscopic polyangiitis (MPA) between 2006 and 2018 and were treated at the Aichi Medical University Hospital in Japan. The relationships between sinusitis and relapse of vasculitis and elevated MPO-ANCA levels were assessed using multivariate Cox proportional hazards models that were adjusted for clinically relevant factors. During the entire follow-up period (median, 24 months; interquartile range, 7-54 months), 93 (89.4%) patients achieved remission. After achieving remission, 38 (40.9%) patients experienced at least one relapse (13 [65.0%] in the sinusitis group; 25 [34.3%] in the non-sinusitis group). Sinusitis was identified as a significant predictor of relapse (adjusted hazard ratio: 2.41, 95% confidence interval [CI]: 1.19-4.88; P = 0.015). Furthermore, sinusitis was more likely to be associated with elevated MPO-ANCA levels (adjusted hazard ratio: 2.59, 95% CI: 1.14-5.92; P = 0.024). In conclusion, sinusitis was associated with a higher risk of relapse and elevated MPO-ANCA levels in MPA patients, suggesting that careful management may be required to reduce the risk of relapse in patients with sinusitis. Further studies are needed to elucidate the optimal treatment strategy for these patients.

Indexed as

AgedAntibodies, Antineutrophil CytoplasmicAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisBiomarkersChronic DiseaseCohort StudiesFemaleGranulomatosis with PolyangiitisHumansJapanMaleMicroscopic PolyangiitisMiddle AgedMyeloblastinPeroxidaseProportional Hazards ModelsAntibodies, Antineutrophil CytoplasmicBiomarkersMyeloblastinPeroxidase

Identifiers

PMID33301468
PMCPMC7728190
OpenAlexW3112246397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.